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Abstract  
Hepatoid adenocarcinoma is a rare subtype of extra-hepatic adenocarcinoma generally characterized by 
hepatocellular carcinoma like foci in the background of adenocarcinoma. Stomach is the most frequent site 
where hepatoid adenocarcinoma occurs, although it has been described in many other organs. We describe a 
case of 16 years old adolescent girl who was diagnosed as a case of “hepatoid adenocarcinoma of stomach’, 
an unlikely presentation at this young age. 
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1. Introduction: 
Gastric adenocarcinoma is a malignant epithelial tumor, originating from glandular epithelium of the 
gastric mucosa. Hepatoid adenocarcinoma (HAC) is a type of extra-hepatic adenocarcinoma, which shows 
a striking morphologic similarity to hepatocellular carcinoma (Gao et al. 2007). It is generally 
characterized by adenocarcinomatous and hepatocellular carcinoma (HCC)-like foci. This variant of 
adenocarcinoma has been demonstrated to be an alpha-fetoprotein (AFP)-producing carcinoma arising in 
extra hepatic organs, and it mimics hepatocellular carcinoma in morphological and functional terms. Alpha-
fetoprotein (AFP) is a fetal serum protein produced by fetal liver and yolk sac cells, and by some fetal 
gastrointestinal cells. After birth, the levels of the protein in serum rapidly decrease. 
 
2. Case report:  
A 16 years old adolescent girl presented with aggravating abdominal pain for 2 months. She had history of 
repeated vomiting, aggravated by food intake for last three months, and anorexia, fatigue and unexplained 
weight loss of ten kilograms over the same duration. The initial ultrasonography was unremarkable with no 
focal defects seen in liver or abdominal lymphadenopathy.  The upper gastrointestinal endoscopy revealed a 
circumferential mass lesion at the gastric antrum occluding the lumen. The biopsies from the antral growth 
showed histological features of fragmented bits of ulcero-necrotic slough, granulation tissue and acute 
inflammatory exudates invaded by several atypical cells with pleomorphic hyperchromatic nuclei, irregular 
nuclear membrane and prominent nucleoli; features highly suggestive of a poorly differentiated malignant 
lesion. Tumor marker (CEA and CA19-9) serum levels were normal. Based on this report the patient 
underwent a distal gastrectomy with dissection of sixteen lymph nodes and biopsy of omental tissue. The 
stomach showed a large tumour of nine centimeters in its greatest axis, with histology showing features of 
“polygonal cells arranged in solid nest, with scattered large multinucleated giant cells, and well 
differentiated papillary pattern with clear cytoplasm – suggestive of Hepatoid Adenocarcinoma”. [Figure 1] 
The carcinoma had infiltrated the muscle coat and had extended into the serosa. The surgical lines of 
resection were free of lesion. Four out of sixteen lymph nodes were positive for metastasis. The omental 
tissue did not show any metastasis. The tumour was immunopositive for cytokeratin and Alpha-fetoprotein 
(AFP) [Figure 2] and negative for C-kit, CD 34, Desmin, SMA and S-100 protein. The postoperative AFP 
was elevated measuring 5090ng/ml. A post-operative CT scan showed multiple liver metastases in both 
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lobes with more on right lobe and portal lymphadenopathy. The patient underwent palliative chemotherapy 
of six cycles comprising of docetaxel, cisplatin and 5fluorouracil.    
 
3. Discussion: 
Stomach cancer is the fourth most common cancer worldwide with 930,000 cases diagnosed in 2002 
(Parkin et al. 2005). The studies show that less than 5% of stomach cancers occur in people less than 40 
years of age with 81.1% of that 5% in the age-group of 30 to 39 and 18.9%  in the age-group of 20 to 29 
(Simsa et al. 2004). The overwhelming pathological variety of gastric carcinoma is adenocarcinoma found 
in 90% of cases. 
Ishikura et al. proposed the term “hepatoid adenocarcinoma of the stomach” for primary gastric carcinomas 
characterized histologically by hepatoid differentiation and the production of large amounts of AFP 
(Ishikura et al. 1985). This unique histological hepatoid adenocarcinoma has also been reported in the lung, 
pancreas, uterus and ovary (Okunaka et al. 1992; Yamada et al. 1994; Itoh et al. 1992; McIntire et al. 
1975). The tumor is immunohistochemistry positive is for cytokeratin and Alpha fetoprotein and negative 
for C-kit, CD 34, Desmin, SMA and S-100 protein.  
There has been mention of case reports of "hepatoid adenocarcinoma of the stomach" in the literature. In 
the literature, 86 cases described by the term “hepatoid adenocarcinoma of the stomach” have been 
reported, including the present case. In 2001, Inawaga et al revised all these cases and published a report 
with the main clinical characteristics of this pathological variety (Inagawa et al. 2001). The average age of 
the patients was 63.5 years (range, 44–87 years), and the male-to-female ratio was 58:25 (the sex was not 
stated for 2 patients). In most of these patients, the tumors occurred mainly at the antrum (60.2%). The 
average serum AFP level was 51130.1 ng/ml (range, less than 1.0–700000ng/ml); that is, much higher than 
normal. Although there were no major symptoms sufficient to allow diagnosis of this type of cancer, 
epigastric pain and general fatigue because of anemia, were the most common symptoms. The average 
maximal tumor diameter was 6.5cm (range, 1.6–14.0cm). Most cases also had metastatic disease to the 
lymph nodes or liver.  
Furthermore, most of the patients died within 2 years of surgery, despite systemic chemotherapy having 
been administered in several patients. These reports suggest that even early stage hepatoid adenocarcinoma 
has an extremely poor prognosis, because of the frequent   occurrence of liver   and/or lymph node 
metastases (Nagai et al. 1993; Chang et al. 1991).  However, the reasons for the poor prognosis are not 
clearly understood. Nagai et al. reported that hepatoid adenocarcinoma had a poor prognosis compared 
with that for AFP-producing non-hepatoid adenocarcinoma (Nagai et al. 1993). One possibility is that 
hepatoid adenocarcinoma produces AAT and/or ACT as well as AFP. AAT and ACT have 
immunosuppressive and protease-inhibiting properties that enhance invasiveness [Redelman & Hudig 
1980; Pasternack & Eisen 1985). Also, AFP has a suppressive effect on lymphocyte transformation. In 
addition, Koide et al. have reported that AFP-producing gastric cancer has high proliferative activity, weak 
apoptosis, and rich neovascularization (Koide et al. 1999). Furthermore, as Chang et al. have reported, 
even if no metastasis is present preoperatively, liver metastasis can occur within a year after surgery, and, 
thus, close observation and long-term follow-up of patients are required (Chang et al. 1991).  
The management of this special subtype has still not clearly been demarcated with majority of patients 
detected in metastatic stage requiring palliative chemotherapy with docetaxel, doxorubicin, cisplatin, 
capecitabine, irinotecan and 5-fluorouracil in various combinations (Van Cutsem et al. 2006; Dank et al. 
2008). The outcome of the subtype is poor for all stages of disease.  
In conclusion, we report a rare case of hepatoid adenocarcinoma of the stomach, diagnosed in an adolescent 
patient with well defined clinicopathological features. The only hope for curative treatment in this rare 
variety of tumour is early diagnosis and administration of novel chemotherapeutic drugs for better disease 
control. 
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Figures: 
 
Figure 1. Gastric biopsy of the distal gastrectomy specimen 400x hematoxylin eosin staining  
 
Figure 2. The gastric biopsy was strongly immnuopositive for AFP 
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